Join to view full profile
450 Brookline AveDana-Farber Cancer InstituteBoston, MA 02215
Phone+1 617-632-3000
Dr. Moody is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2011
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2005
Certifications & Licensure
MA State Medical License 2007 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2014
Publications & Presentations
PubMed
- 10 citationsA compendium of Amplification-Related Gain Of Sensitivity genes in human cancer.Veronica Rendo, Michael Schubert, Nicholas Khuu, Maria F Suarez Peredo Rodriguez, Declan Whyte
Nature Communications. 2025-01-27 - 35 citationsCellular dormancy in minimal residual disease following targeted therapy.Jason R. Ruth, Dhruv K. Pant, Tien-chi Pan, Hans E. Seidel, Sanjeethan C. Baksh
Breast Cancer Research. 2021-06-04 - 119 citationsPhase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumoursJordi Rodon, Guillem Argiles, Roisin M. Connolly, Ulka N. Vaishampayan, Maja J.A. de Jonge
British Journal of Cancer. 2021-05-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










